Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer

Summary. At present, there are no valid prognostic biomarkers in patients with triple negative breast cancer (TNBC) except well known clinical factors such as tumor size, lymph node status, differentiation grade and proliferation rate. Aim: To evaluate the prognostic role of androgen receptor (AR) e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Datum:	2023
Hauptverfasser:	Lyalkin, S.A., Verevkina, N.O., Alekseyenko, O.O., Syvak, L.A.
Format:	Artikel
Sprache:	English
Veröffentlicht:	PH Akademperiodyka 2023
Schlagworte:	androgen receptor clinical prognosis overall survival triple negative breast cancer
Online Zugang:	https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-9
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Experimental Oncology

Institution

Experimental Oncology

Ähnliche Einträge

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
von: Tsyhyka, D.Y., et al.
Veröffentlicht: (2013)

Integral characteristic of the immune system state predicts breast cancer outcome
von: Stakheyeva, M., et al.
Veröffentlicht: (2023)

Prognostic factors in metastatic gastric carcinoma
von: Ben Kridis, W., et al.
Veröffentlicht: (2023)

Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
von: Kovalev, A.A., et al.
Veröffentlicht: (2013)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

High expression of GLI1 is associated with better survival in advanced SCLC
von: Kozirovskis, V., et al.
Veröffentlicht: (2023)

Deletions in metastatic colorectal cancer with chromothripsis
von: Skuja, E., et al.
Veröffentlicht: (2023)

A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer
von: Yazici, O., et al.
Veröffentlicht: (2013)

Epigenetics in breast cancer
von: Atalay, C.
Veröffentlicht: (2013)

Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
von: Yalcin, B.
Veröffentlicht: (2013)

Positron emission tomography/computed tomography in locally advanced breast cancer
von: Ozkan, E.
Veröffentlicht: (2013)

Staging, risk assessment and screening of breast cancer
von: Yalcin, B.
Veröffentlicht: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
von: Akyurek, S., et al.
Veröffentlicht: (2013)

Postmastectomy radiation therapy in locally advanced breast cancer
von: Yavas, G., et al.
Veröffentlicht: (2013)

Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
von: Semesiuk, N., et al.
Veröffentlicht: (2013)

Male breast cancer: clinical presentation, diagnosis, treatment
von: Hotko, Y.S.
Veröffentlicht: (2013)

Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches
von: Eroğlu, A., et al.
Veröffentlicht: (2013)

Breast reconstruction
von: Kaya, B., et al.
Veröffentlicht: (2013)

Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
von: Burlaka, A.P., et al.
Veröffentlicht: (2023)

Detection of breast cancer presenting as a mass in women with dense breasts — digital breast tomosynthesis versus full-field digital mammography
von: Babkina, T.M., et al.
Veröffentlicht: (2023)

Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
von: Chekhun, V.F., et al.
Veröffentlicht: (2023)

Incidence and long-term effects of treatment of malignant germ cell neoplasms in Ukraine
von: Fedorenko, Z.P., et al.
Veröffentlicht: (2023)

Antiproliferative and apoptotic effects of anti-human HB-EGF neutralizing polyclonal antibodies in vitro
von: Siromolot, A.A., et al.
Veröffentlicht: (2023)

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma
von: Çavuş, B., et al.
Veröffentlicht: (2023)

Tumor microenvironment and metabolic factors: contribution to gastric cancer
von: Bubnovskaya, L., et al.
Veröffentlicht: (2023)

FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
von: Arabpour, F., et al.
Veröffentlicht: (2018)

Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
von: Kravets, O.V., et al.
Veröffentlicht: (2023)

FUT3 expression in human breast cancer cells under hypoxia and serum deprivation
von: Albuquerque, A.P.B., et al.
Veröffentlicht: (2023)

Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival
von: Korovin, S., et al.
Veröffentlicht: (2023)

The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
von: Dumanskiy, Y.V., et al.
Veröffentlicht: (2023)

The impact of maximal strength training on quality of life among women with breast cancer undergoing treatment
von: Cešeiko, R., et al.
Veröffentlicht: (2023)

Bladder sparing surgery in high-grade bladder cancer
von: Yakovlev, P.G., et al.
Veröffentlicht: (2023)

Prognosis models of nitrates and orthophosphates content in surface waters
von: Mitryasova, Olena P., et al.
Veröffentlicht: (2022)

NANOG as prognostic factor of prostate cancer course
von: Zadvornyi, T.V., et al.
Veröffentlicht: (2023)

A network model for structural survivability
von: Додонов, О. Г., et al.
Veröffentlicht: (2021)

HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme — case-control study in breast cancer
von: Bialik, P., et al.
Veröffentlicht: (2023)

Expression pattern of genes associated with tumor microenvironment in prostate cancer
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
von: Kirkilevsky, S.I., et al.
Veröffentlicht: (2023)

Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors
von: Shcherbina, V., et al.
Veröffentlicht: (2023)

Overexpression of the mitochondrial ribosomal protein S18-2 in the invasive breast carcinomas
von: Buchynska, L.G., et al.
Veröffentlicht: (2018)